Related Experiment Video
Updated: Feb 3, 2026

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
Prevalence of bowel dysfunction in multiple sclerosis. A population survey
J P Hinds1, B H Eidelman, A Wald
1Gastroenterology Unit, Montefiore Hospital, Pittsburgh, Pennsylvania.
Bowel dysfunction, including constipation and fecal incontinence, affects 68% of multiple sclerosis patients. This common condition significantly impacts social well-being and warrants further investigation for effective treatments.
Area of Science:
- Neurology
- Gastroenterology
- Epidemiology
Background:
- Multiple sclerosis (MS) is a chronic neurological disease.
- Bowel dysfunction is a frequently reported but often understudied complication in MS.
- Understanding the prevalence and characteristics of bowel dysfunction in MS is crucial for patient care.
Purpose of the Study:
- To determine the prevalence of bowel dysfunction (constipation and fecal incontinence) in an unselected outpatient MS population.
- To characterize the relationship between bowel dysfunction and disease parameters (disability, duration) and other MS symptoms.
- To assess the impact of bowel dysfunction on patients' social functioning.
Main Methods:
- Survey of 280 outpatient individuals with multiple sclerosis.
- Detailed questionnaires assessing constipation and fecal incontinence.
- Correlation analysis with disability, disease duration, genitourinary symptoms, and medication use.
Main Results:
- Overall bowel dysfunction prevalence was 68% (43% constipation, 51% experienced fecal incontinence in the prior 3 months).
- Constipation and fecal incontinence were common even in mildly disabled patients.
- Bowel dysfunction correlated with disease duration and genitourinary symptoms, but not medication use in mildly disabled patients.
Conclusions:
- Bowel dysfunction is highly prevalent in multiple sclerosis patients, irrespective of disability level.
- This manifestation contributes significantly to social disability.
- Further research into the pathophysiology is needed to develop targeted therapeutic strategies.
Related Concept Videos
07:45Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8+ T Cells During Tumorigenesis
09:17A DNA/Ki67-Based Flow Cytometry Assay for Cell Cycle Analysis of Antigen-Specific CD8 T Cells in Vaccinated Mice
10:13Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
08:37In Situ MHC-tetramer Staining and Quantitative Analysis to Determine the Location, Abundance, and Phenotype of Antigen-specific CD8 T Cells in Tissues
06:25Analysis of Simian Immunodeficiency Virus-specific CD8+ T-cells in Rhesus Macaques by Peptide-MHC-I Tetramer Staining
14:29Examination of Thymic Positive and Negative Selection by Flow Cytometry

